Abstract:Background and Purpose - Human brain arteriovenous malformation tissue displays increased levels of vascular endothelial growth factor (VEGF) as well as matrix metalloproteinase (MMP)- 9, a tissue protease associated with various intracerebral hemorrhage (ICH). We hypothesized that increased MMP- 9 was associated with ICH induced by vascular endothelial growth factor hyperstimulation and that this effect could be attenuated by nonspecific MMP inhibition.Methods - We used a mouse model with adenoviral vector- mediated vascular endothelial growth factor transduction in the brain. The association of MMP- 9 expression and the brain tissue hemoglobin levels, an index of ICH, after stereotactic injection of adenoviral vector- mediated vascular endothelial growth factor into caudate putamen was assessed. A dose - response study with adenoviral vector- mediated vascular endothelial growth factor and a time course study at both 24 and 48 hours postinjection were performed. Effects of minocycline, a nonspecific MMP inhibitor, and pyrrolidine dithiocarbamate, an upstream regulator of MMPs, on MMP- 9 activity and thereby the degree of ICH were also tested.Results - Adenoviral vector- mediated vascular endothelial growth factor at the higher dose and at 48 hours induced MMP- 9 levels 6- fold (n = 6, P = 0.02) and increased brain tissue hemoglobin (43.4 +/- 11.5 versus 30.3 +/- 4.1 mu g/mg, n = 6, P = 0.003) compared with the adenoviral vector control. Immnunostaining was positive for MMP- 9 around the cerebral vessels and the hemorrhagic areas. Minocycline and pyrrolidine dithiocarbamate administration suppressed vascular endothelial growth factor- induced MMP- 9 activity (n = 6, P = 0.003 and P = 0.01, respectively) and the associated increases in hemoglobin levels (n = 5 - 6, P = 0.001 and P = 0.02, respectively).Conclusions - Vascular endothelial growth factor- induced ICH is associated with increased MMP- 9 expression. Suppression of MMP- 9 by minocycline or pyrrolidine dithiocarbamate attenuated ICH, suggesting the therapeutic potential of MMP inhibitors in cerebral vascular rupture.

Matrix Metalloproteinase-9 and Ischemic Cerebrovascular Diseases

Relationship Between Matrix Metalloproteinase-9 and Tissue Metalloproteinase Inhibitor-1 and Carotid Atheromatous Plaque Stability

Mmp-9, a Potential Target for Cerebral Ischemic Treatment.

MMP-9 Relative to Hemorrhagic Transformation of Cerebral Infarction and Its Research Progress

A Therapeutic Target Of Cerebral Hemorrhagic Stroke: Matrix Metallo-Proteinase-9

Ischemic Postconditioning Diminishes Matrix Metalloproteinase 9 Expression and Attenuates Loss of the Extracellular Matrix Proteins in Rats Following Middle Cerebral Artery Occlusion and Reperfusion

Matrix Metalloproteinase-9 Inhibition Attenuates Vascular Endothelial Growth Factor-Induced Intracerebral Hemorrhage

Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke

Study of matrix metalloproteinase 9 expression after mice ischemia/reperfusion in hippocampus and treatment effects of Yangyin Tongnao granule(养阴通脑颗粒)

Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia

The Change of Matrix Metalloproteinase-9 Early Expression after Cerebral Ischemia-Reperfusion Injury

Early Expression of Matrix Metalloproteinase 9 and Blood-Brain Barrier Disruption after Transient Cerebral Ischemia-Reperfusion in Rats

Effects of matrix metalloproteinase 9 inhibition on the blood brain barrier and inflammation in rats following cardiopulmonary resuscitation.

Potential Contribution of Matrix Metalloproteinase-9 (Mmp-9) to Cerebral Vasospasm after Experimental Subarachnoid Hemorrhage in Rats.

Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Expression in Early Focal Cerebral Infarction Following Urokinase Thrombolysis in Rats

Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke

Expression of MMP-9 after Cerebral Ischemic Reperfusion and the Effects of Artificial Synthetic E-selectin in Rats

Clinical Investigation of the Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase in Prehamatomal Brain Regions in Patients with Hypertensive Intracerebral Hemorrhage

MMP-9 and Ultrastructural Study of Intracranial Aneurysms

Activation of Cerebral Recovery by Matrix Metalloproteinase-9 after Intracerebral Hemorrhage

Lentivirus-Mediated Transfer Of Mmp-9 Shrna Provides Neuroprotection Following Focal Ischemic Brain Injury In Rats